Address
SV Life Sciences Advisers Inc
201 Washington Street
Suite 3900, One Boston Place
Boston, MA 02108
United States
Phone
Website
Recent investment activity
KANDO id: 2179
Corporate information
Official name
SV Life Sciences Advisers Inc
Registration country
Funding rounds
Investment activity status
Not investing
Selected investments
Displaying 1 - 25 of 51| Company | Profile | Country | Date | Funding | ||
|---|---|---|---|---|---|---|
![[current-page:title] logo](/sites/default/files/styles/icon/public/default_images/_no-logo.png?itok=AH4pbDYM){kind=icon}
|
Alder Biopharmaceuticals Inc | Developer of antibody therapeutics. | N/A | |||
|
|
Allegiance Hospice Group Inc | Hospice provider serving patients in New England. | N/A | |||
|
|
Allos Therapeutics Inc | N/A | ||||
|
|
Archemix Corp | A biotechnology company, engages in discovering, developing, and commercializing aptamer therapeutics for the treatment of life threatening diseases. | N/A | |||
|
Auxilium Pharmaceuticals Inc | N/A | ||||
|
|
CardioKinetix Inc | N/A | ||||
|
|
Catabasis Pharmaceuticals Inc | Series A | ||||
|
|
Catabasis Pharmaceuticals Inc | Series A | ||||
|
|
Confluent Surgical Inc | A medical device company leading in the field of surgical sealants and adhesion barriers for use in neurosurgery, gynecologic and general surgery. | Series D | |||
|
|
CSA Medical Inc | CSA Medical has advanced the proven science of cryotherapy. | N/A | |||
|
|
Delenex Therapeutics AG | Series A | ||||
|
|
EBR Systems Inc | A venture-backed clinical stage company founded to develop implantable systems for wireless tissue stimulation | Series C | |||
|
|
ESBATech AG | Switzerland based Biomedical Research Unit of Alcon | Series B | |||
|
|
Eyetech Pharmaceuticals Inc | Biopharmaceutical company that specializes in the development and commercialization of novel therapeutics to treat diseases of the eye. | N/A | |||
|
|
Imagen Biotech Inc | N/A | ||||
|
|
Insulet Corp | N/A | ||||
|
|
Intranasal Therapeutics Inc | Specialty pharmaceutical company focused on developing nasally delivered pharmaceutical products. | N/A | |||
|
|
Link Medicine Inc | Advancing disease-modifying technologies targeted at Alzheimer's, Parkinson's and other neurodegenerative diseases | Series C | |||
|
|
Logical Therapeutics Inc | An early stage biotechnology company | N/A | |||
|
|
Lux Biosciences Inc | Clinical stage biotechnology company specializing in the development and commercialization of innovative medications for serious ophthalmic diseases. | N/A | |||
|
|
Mpex Pharmaceuticals Inc | N/A | ||||
|
|
NeurogesX Inc | N/A | ||||
|
|
Neurotech Pharmaceuticals Inc (Neurotech Inc) | Cell-based drugs for diseases of the eye. | Series B | |||
|
|
Ophthotech Corp | Clinical-stage biotechnology company, engages in developing and commercializing therapies for wet and dry age-related macular degeneration. | N/A | |||
|
|
Phase Forward Inc | N/A |
Team
Former team members
| Employee | Company | Position | |||
|---|---|---|---|---|---|
| Ken Macleod | Paul Capital Advisors UK Ltd | [email protected] |